Recommended Alerts

Sign Up For Alerts

The Application of the UK’s NSIA to Life Sciences Transactions

The UK’s National Security and Investments Act (“NSIA”) came into force today, granting the UK Government, through the Department for Business, Energy & Industrial Strategy (“BEIS”), the power to review transactions that may give rise to a national security risk.

Read More

Supreme Court Rejects Bright-Line Test For Materiality in Rule 10b-5 Class Action With Respect to Adverse Event Reports

Practices: Life Sciences, Corporate & Securities Litigation, Securities & Public Companies Industries: Biotechnology & Pharmaceuticals

Printer-Friendly Version

Cookie Settings